期刊文献+

PARs与消化系肿瘤关系的研究进展 被引量:5

Advances in the relationship between protease-activated receptors and digestive system tumors
下载PDF
导出
摘要 蛋白酶激活受体(protease-activated receptor,PARs)家族是一类与G蛋白相偶联、有7个跨膜单位的受体家族,广泛分布于消化系统脏器及组织.PARs与消化系肿瘤关系密切,主要表现在PARs在肿瘤组织中高表达,其表达与肿瘤的恶性程度及侵袭转移能力正相关性.体外研究表明,利用PARs的激动剂干预肿瘤细胞,可加强其增殖、侵袭转移能力.PARs对肿瘤细胞增殖、侵袭能力的调控依赖于多种信号转导途径,其作用机制尚不明确,现就此作一综述. Protease-activated receptors(PARs),belonging to a family of G-protein-coupled seven-transmembrane-domain receptors,are widely distributed in digestive organs.PARs are highly expressed in digestive system tumors,and their expression is positively correlated with the malignancy, invasiveness and metastasis of digestive system neoplasm.PAR agonists are able to promote the proliferation,invasion and metastasis of tumor cells in vitro.The role of PARs in tumor cells depends on a variety of signal transduction pathways. However, the mechanism underlying their role in the proliferation, invasion and metastasis of tumor cells remains unclear. In this article, we will review their role in the development and progression of digestive system tumors and the molecular mechanism underlying such role.
作者 李轩 谢立群
出处 《世界华人消化杂志》 CAS 北大核心 2009年第21期2179-2183,共5页 World Chinese Journal of Digestology
关键词 蛋白酶激活受体 肿瘤 消化系统 Protease-activated receptor Tumor Digestive system
  • 相关文献

参考文献30

  • 1Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84:579-621.
  • 2Kahn ML, Hammes SR, Botka C, Coughlin SR. Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem 1998; 273:23290-23296.
  • 3Hollenberg MD. Protease-activated receptors: PAR4 and counting: how long is the course? Trends Pharmacol Sci 1999; 20:271-273.
  • 4Damiano BP, Derian CK, Maryanoff BE, Zhang HC, Gordon PA. RWJ-58259: a selective antagonist of protease activated receptor-1. Cardiovasc Drug Rev 2003; 21:313-326.
  • 5Hembrough TA, Swerdlow B, Swartz GM. Novel antagonists of Par-2: inhibition of tumor growth, angiogenesis, and inflammation. Blood 2005; 104:11.
  • 6Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG. Proteaseactivated receptor I mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000; 191:455-462.
  • 7Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endotheliumdependent relaxations to PAR2 and PAR4 agonists. Circ Res 2001; 89:92-98.
  • 8Brass LF. Thrombin receptor antagonists: a work in progress. Coron Artery Dis 1997; 8:49-58.
  • 9Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Patho12003; 162:1503-1513.
  • 10Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 2001; 85:772-779.

同被引文献111

  • 1汪涌,邵晨,师长宏,张运涛,刘凡,王禾.雄激素依赖性前列腺癌细胞在其雄激素受体阻断后细胞周期基因表达的改变[J].中华实验外科杂志,2004,21(11):1337-1338. 被引量:13
  • 2郭艳丽,闫慧明,宋善俊.组织因子、尿激酶型纤溶酶原激活剂受体mRNA在人乳腺癌中的表达[J].肿瘤学杂志,2005,11(2):113-115. 被引量:1
  • 3窦勇鹰,谢立群,李俊美,华建平.蛋白酶激活受体的研究进展[J].世界华人消化杂志,2006,14(12):1206-1209. 被引量:5
  • 4卢希,韩昱晨.Rho蛋白在肿瘤的侵袭、转移中的作用[J].实用肿瘤学杂志,2007,21(3):296-298. 被引量:6
  • 5Koshikawa N,Hasegawa S,Nagashima Y,et al.Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse [J].Am J Pathol, 1998,153 (3):937-944.
  • 6Shimamoto R,Sawada T,Uchima Y,et al.A role for pro- tease-activated receptor-2 in pancreatic cancer cell prolife- ration[J].Int J Oncol, 2004,24(6): 1401-1406.
  • 7Yamamoto H,Iku S,Adachi Y,et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer [J].J Pathol, 2003,199(2): 176-184.
  • 8Li Z,Bian LJ,Li Y,et al.Expression of protease-activated receptor-2 (PAR-2)in patients with nasopharyngeal carci- noma:correlation with clinicopathological features and prognosis[J].Pathol Res Pract, 2009,205 (8):542-550.
  • 9Hedstrom J, Haglund C, Leinonen J, et al .Trypsinogen-1, - 2 and tumour-associated trypsin-inhibitor in bile and bi- liary tract tissues from patients with biliary tract diseases and pancreatic carcinomas [J].Scand J Clin Lab Invest, 2001,61(2):111-118.
  • 10Williams SJ,Gotley DC ,Antalis TM.Human trypsinogen in colorectal cancer[J].Int J Cancer, 2001,93(1):67-73.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部